Connect with us

Hi, what are you looking for?

Right Decision NowRight Decision Now

World News

Hospitals ‘extremely’ busy as COVID spreads in China

CHENGDU — Chinese hospitals were under intense pressure on Wednesday as a surge of coronavirus disease 2019 (COVID-19) infections strained medical resources, while the scale of the outbreak and doubts over official data prompted some countries to consider new travel rules on Chinese visitors.

In an abrupt change of policy, China this month began dismantling the world’s strictest COVID regime of lockdowns and extensive testing, putting its battered economy on course for a complete reopening next year.

The lifting of restrictions, which came after widespread protests against them, means COVID is spreading largely unchecked and likely infecting millions of people a day, according to some international health experts.

The speed at which China, the last major country in the world moving towards treating the virus as endemic, has scrapped COVID rules has left its fragile health system overwhelmed.

China reported three new COVID-related deaths for Tuesday, up from one for Monday — numbers that are inconsistent with the experience of much less populous countries after they reopened.

Staff at Huaxi, a big hospital in the southwestern city of Chengdu, said they were “extremely busy” caring for patients with COVID, as they have been ever since curbs were eased on Dec. 7.

“I’ve been doing this job for 30 years and this is the busiest I have ever known it,” said one ambulance driver outside the hospital who declined to be identified.

There were long queues inside and outside the hospital’s emergency department and at an adjacent fever clinic on Tuesday evening. Most of those arriving in ambulances were given oxygen to help with their breathing.

“Almost all of the patients have COVID,” one emergency department pharmacy staff member said.

The hospital has no stocks of COVID-specific medicine and can only provide drugs for symptoms such as coughing, she said.

Zhang Yuhua, an official at the Beijing Chaoyang Hospital, said most recent patients were elderly and critically ill with underlying diseases. She said the number of patients receiving emergency care had increased to 450-550 per day, from about 100 before, according to state media.

The China-Japan Friendship Hospital’s fever clinic in Beijing was also “packed” with gray-haired patients, state media reported.

Nurses and doctors have been asked to work while sick and retired medical workers in rural communities were being rehired to help. Some cities have been struggling to secure supplies of anti-fever drugs.

Pictures published by state-run China Daily showed rows of mostly elderly patients, some breathing through oxygen tubes, receiving treatment from medical staff in white hazmat suits in the hospital’s intensive care unit.

TRAVEL RULES
In a major step towards freer travel, China will stop requiring inbound travelers to go into quarantine from Jan. 8, authorities said this week, prompting many Chinese, cut off from the world for so long, to check travel platforms.

But while online searches for flights spiked on Tuesday from extremely low levels, residents and travel agencies suggested a return to anything like normal would take some months yet, given worries about COVID and more careful spending because of the impact of the pandemic.

Moreover, some governments were considering extra travel requirements for Chinese visitors.

US officials cited “the lack of transparent data, including viral genomic sequence data” as reasons for doing so.

India and Japan would require a negative COVID test for travelers from mainland China, with those testing positive in Japan having to undergo a week in quarantine. Tokyo also plans to limit airlines increasing flights to China.

The Philippines should be “very cautious” when receiving inbound travelers from China, its transportation minister said on Wednesday, adding the country was considering imposing testing requirements.

Asked about the travel requirements imposed by Japan and India, a spokesman for China’s foreign ministry said on Tuesday “COVID measures should be scientific, moderate and should not affect the normal flow of individuals.”

China’s $17 trillion economy is expected to suffer a slowdown in factory output and domestic consumption as workers and shoppers fall ill.

News of China reopening its borders sent global luxury stocks higher, but the reaction was more muted in other corners of the market, as the worlds second-largest economy is likely to face subdued global demand in 2023. 

US carmaker Tesla plans to run a reduced production schedule at its Shanghai plant in January, extending the restricted output it began this month into next year, according to an internal schedule reviewed by Reuters.

Tesla did not specify a reason for the planned production slowdown.

Once the initial shock of new infections passes, some economists expect Chinese growth to bounce back with a vengeance from what is this year expected to be its lowest rate in nearly half a century, somewhere around 3%.

Morgan Stanley economists expect 5.4% growth in 2023, while those at Goldman Sachs see 5.2%. — Reuters

    You May Also Like

    Business

    The head of the International Monetary Fund has warned of increased risks to the stability of the financial system after weeks of banking sector...

    World News

    BEIJING — China landed an uncrewed spacecraft on the far side of the moon on Sunday, overcoming a key hurdle in its landmark mission...

    World News

    LONDON — Talks aimed at reaching a global agreement on how to better fight pandemics will be concluded by 2025 or earlier if possible,...

    World News

    SINGAPORE — Ukrainian President Volodmyr Zelensky’s unscheduled appearance at Asia’s biggest security conference dominated proceedings on Sunday after China’s defense chief slammed “separatists” in...

    Disclaimer: rightdecisionnow.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 rightdecisionnow.com | All Rights Reserved